276 related articles for article (PubMed ID: 19732534)
1. [Prescription of topical immunomodulators].
Rosenzweig M
Ugeskr Laeger; 2009 Aug; 171(35):2472-6. PubMed ID: 19732534
[TBL] [Abstract][Full Text] [Related]
2. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
[TBL] [Abstract][Full Text] [Related]
3. Off-label topical calcineurin inhibitor use in children.
Manthripragada AD; Pinheiro SP; MaCurdy TE; Saneinejad S; Worrall CM; Kelman JA; Graham DJ
Pediatrics; 2013 Nov; 132(5):e1327-32. PubMed ID: 24127469
[TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
Horii KA; Simon SD; Liu DY; Sharma V
Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
[TBL] [Abstract][Full Text] [Related]
6. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
Werfel T
J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
[TBL] [Abstract][Full Text] [Related]
7. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
Bos JD
Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
[TBL] [Abstract][Full Text] [Related]
10. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
11. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
12. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
13. [Local treatment of atopic dermatitis with calcineurin inhibitors].
Langeland T
Tidsskr Nor Laegeforen; 2006 Jan; 126(3):321-2. PubMed ID: 16440040
[No Abstract] [Full Text] [Related]
14. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
Zuberbier T; Bräutigam M
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
[TBL] [Abstract][Full Text] [Related]
15. Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application.
Weiss HM; Fresneau M; Moenius T; Stuetz A; Billich A
Drug Metab Dispos; 2008 Sep; 36(9):1812-8. PubMed ID: 18524871
[TBL] [Abstract][Full Text] [Related]
16. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
17. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
Meurer M; Lubbe J; Kapp A; Schneider D
Dermatology; 2007; 215 Suppl 1():18-26. PubMed ID: 18174690
[TBL] [Abstract][Full Text] [Related]
18. Topical pimecrolimus in the treatment of vitiligo.
Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM
Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829
[TBL] [Abstract][Full Text] [Related]
19. [Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ].
MMW Fortschr Med; 2003 Jul; 145(29-30):62. PubMed ID: 12958787
[No Abstract] [Full Text] [Related]
20. Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
Van Leent EJ; De Vries HJ; Ebelin ME; Burtin P; Scott G; Bos JD
J Dermatolog Treat; 2007; 18(1):19-22. PubMed ID: 17365262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
